Ascendia

25 Year BadgeDrug Development & Delivery Celebrates 25 Years!

For a quarter century, Drug Development & Delivery has connected innovators, scientists, and industry leaders while spotlighting the technologies and ideas shaping the future of the industry. We celebrate 25 years of advancing the conversation!

  MARKET NEWS

 

PacBio, TychoBio Join Forces to Build AI Models for Rare Disease RNA Therapies
Biopharma Industry Launches Consortium to Build Digital Standards for CMC
CPHI Broadens European Strategy With New Spain Event and Specialist Frankfurt Zones
Upperton Unveils New Brand as it Expands Specialist CDMO Offering
Ofichem to Acquire Kinentia Biosciences, Expanding US Drug Substance Footprint
SGD Pharma Broadens Glass Vial Portfolio With New Nasal and RTU Offerings
CPHI Milan Brings Pharma Industry Together for Practical Sustainability Summit
Agilent Adds Boulder Lab to Expand Oligonucleotide Manufacturing Capabilities
Credence MedSystems Earns ISO 13485 Certification as it Expands Drug Delivery Manufacturing Readiness

  EXPERT CONTENT & RESOURCES

Monoclonal vs Polyclonal Antibody Production

Monoclonal vs Polyclonal Antibody Production

Antibody-based therapeutics have reshaped modern medicine. With demand soaring, choosing the appropriate production path can save months and millions.

Modeling Polymor Interactions to Improve Amorphous Dispersion Design

Modeling Polymor Interactions to Improve Amorphous Dispersion Design

In this case study, OSDPredict™ narrowed formulation options early, focusing development on the most viable strategies which reduced experimental burden and conserved valuable materials.

The Last Mile of Digital Implementation: A Technical Framework for Turning Clinical Technology Adoption Into Measurable Value

The Last Mile of Digital Implementation: A Technical Framework for Turning Clinical Technology Adoption Into Measurable Value

As clinical trials become increasingly digitally enabled, organizations must look beyond successful technology deployment to determine whether new tools are delivering measurable value. This article presents a five-layer framework for evaluating technical fitness, workflow integration, adoption, data reliability, and operational outcomes to help translate clinical technology investments into better trial execution and evidence.

  FEATURED EDITORIAL

  EXPERT INSIGHTS VIDEOS

Oral Peptide Drug Delivery: Overcoming Bioavailability & Formulation Challenges

Oral Peptide Drug Delivery: Overcoming Bioavailability & Formulation Challenges

  COMPANY PROFILE

Logo

ProMed Pharma is your distinguished development partner in long-acting injectable and implantable dosage forms. With nearly 20 years of operational history, we have honed our expertise in polymer-based dosage forms, achieving mastery in extended-release dosing. Our proficiency spans molding, extrusion, and microencapsulation techniques, leveraging a diverse spectrum of polymeric excipients encompassing silicones, thermoplastics, and biodegradables. At ProMed Pharma, our commitment to rapid project execution is underpinned by a steadfast dedication to scientific inquiry and technical finesse. Whether you represent an emerging biotech venture or a global pharmaceutical entity, entrust us as your CDMO partner, as we diligently translate scientific concepts into finished dosage forms.

Click here for more.

 

Logo

As Part of Terumo Medical Care Solutions, the Pharmaceutical Solutions Division develops patient-oriented parenteral delivery solutions for therapeutic performance and safety.

Globally trusted for quality and precision, we offer pharmaceutical and medical device manufacturers around the world comprehensive product design and development services.

We have decades of experience collaborating with pharmaceutical companies from the earliest phases of drug development to product commercialization to optimize critical aspects of parenteral drug delivery.

Click here for more.

 

  WHITEPAPERS & WEBINARS

WHITEPAPER - Large-Scale LNP Process Conversions

WHITEPAPER - Large-Scale LNP Process Conversions

Large-Scale LNP Process Conversions: The many hurdles of LNP scale-up and what to consider

Lipid nanoparticle (LNP) formulation development begins on a small scale, often with homemade or benchtop setups, using syringe pumps and easily accessible micro-mixing systems. Once …

WEBINAR - Challenges of Sustained Release Drug Delivery Devices

WEBINAR - Challenges of Sustained Release Drug Delivery Devices

Sustained release drug delivery is rapidly expanding across respiratory, ophthalmic, transdermal, and implantable applications, but translating products from development to manufacturing remains both complex and costly. Programs can stall due to material–drug compatibility issues, inconsistent release profiles, tooling-related variability, and …

WHITEPAPER - Streamlined Product Development Leveraging Pharmaceutical Classification Models

WHITEPAPER - Streamlined Product Development Leveraging Pharmaceutical Classification Models

A technology agnostic approach based on a fundamental understanding of API properties, a well-defined yet flexible target product profile, and a mindset for scalability and commercial relevance leads to success in formulation development and drug product design.

In this whitepaper, …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

October 14 – Injection Devices
October 21 – Transdermal/Topical Delivery
October 28 – Formulation Development
November 4 – Drug Delivery

To advertise in a future eNewsletter contact:

John Kiesewetter jkiesewetter@drug-dev.com
Amy Nicklaus anicklaus@drug-dev.com

Submit eNewsletter content:

Cindy Dubin cdubin@drug-dev.com
Ralph Vitaro rvitaro@drug-dev.com